Sclerotherapy for Hydroceles

Abstract

No AccessJournal of Urology1 May 1990Sclerotherapy for Hydroceles Rupert K. Rencken, Maria S. Bornman, Simon Reif, and Ilse Olivier Rupert K. RenckenRupert K. Rencken More articles by this author , Maria S. BornmanMaria S. Bornman More articles by this author , Simon ReifSimon Reif More articles by this author , and Ilse OlivierIlse Olivier More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)40145-5AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Sclerotherapy with 3% sodium tetradecyl sulfate and 3.5% rolitetracycline on an outpatient basis was applied to 55 hydroceles. The over-all cure rate was 96% with an average followup of 13 months. Of the patients 64% were cured after only 1 sclerosant instillation. A post-sclerotherapy operation was necessary in 4% of the patients. Pain of a significant degree occurred after sclerotherapy in only 29% of the patients. Sclerotherapy appears to be an effective, economical and safe form of outpatient therapy for hydroceles. (J. Urol., 143: 940–943, 1990) © 1990 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 143Issue 5May 1990Page: 944-947 Advertisement Copyright & Permissions© 1990 by The American Urological Association Education and Research, Inc.MetricsAuthor Information Rupert K. Rencken More articles by this author Maria S. Bornman More articles by this author Simon Reif More articles by this author Ilse Olivier More articles by this author Expand All Advertisement PDF DownloadLoading ...